title: A challenge to the therapeutic nihilism of ESPAC-1.
authors.forename: Mary C
authors.initials: MC
authors.lastname: Koshy
authors.forename: Jerome C
authors.initials: JC
authors.lastname: Landry
authors.forename: Sean X
authors.initials: SX
authors.lastname: Cavanaugh
authors.forename: Clifton D
authors.initials: CD
authors.lastname: Fuller
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Willett
authors.forename: Ross A
authors.initials: RA
authors.lastname: Abrams
authors.forename: John P
authors.initials: JP
authors.lastname: Hoffman
authors.forename: Charles R
authors.initials: CR
authors.lastname: Thomas
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D019540:Area Under Curve; D015982:Bias; D003131:Combined Modality Therapy; D003627:Data Interpretation, Statistical; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D015337:Multicenter Studies as Topic; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil